Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Oden6570 on Feb 25, 2021 8:12am

Big News !

Over at the company that shall not be named ! But read back just a wee bit .
Comment by StevenBirch on Feb 25, 2021 8:30am
Thanks Oden/Thor, because of your sharing of information here during slow news periods or boring political rants I have been able to benefit from your research. And now both companies seem to entering exciting times for a group of us here. Again thank you.
Comment by Oden6570 on Feb 25, 2021 8:54am
Your welcome, I do notice an ever increasing amount of long TLT posters on the unnamed companies BB's. Makes the waiting much easier here.
Comment by skyhawk1 on Feb 25, 2021 9:46am
Yeah it's been a very satisfying WAIT on TLT to get their MOJO going while investing over there in BOTH of those remarkable companies!! This NEWS really blows the DOORS WIDE OPEN on the ENDLESS possibilities of future ENERGY storage & usage going forward!! NOW LIKE I SAID YESTERDAY PLEASE PUT UR MIGHTY HAMMER TO WORK OVER HERE WITH TLT AS WELL?! THX!  LoL  
Comment by Bunge on Feb 25, 2021 9:16am
No worries here. You, StevenBirch, Yajne, few others got me researching over there and I'm up $20G. So thanks again. P.S. I saw benny (claridge, peer reviewed, science first) was over on the board trying to poo-poo HPQ.  WARNING everyone the m/c was too high. Bought too soon? OH BENNY! LOL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250